Active

CHERRY PHARMA LIMITED Financials

Company number
08007799Copy
Copy
Registered office
12 Hill Drive, Kingsbury, London NW9 8PH
Incorporated
27/03/2012

Company snapshot

Status
Active
Employees
23 (2025)
Latest financial data
2025
Accounts type
Unaudited abridged

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2025.

Net Assets

£66.04K2025
4.22%vs 2024

2024: £63.37K

Total Assets

£530.98K2025
-12.27%vs 2024

2024: £605.22K

Cash in Bank

£3.65K2025
-90.43%vs 2024

2024: £38.19K

Total Liabilities

£459.29K2025
-15.04%vs 2024

2024: £540.61K

Employees

232025
+3vs 2024

2024: 20

In 2025, CHERRY PHARMA LIMITED reported net assets of £66.04K. The same filing shows total assets of £530.98K, cash in bank of £3.65K and total liabilities of £459.29K. Reported headcount was 23 in 2025. Total Liabilities fell from £540.61K in 2024 to £459.29K in 2025 (-15.04%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£66.04K2025
4.22%from £63.37K in 2024

Year-on-year change

Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.

3-year financial trend (2023–2025)

How the figures CHERRY PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.

Net Assets

£67.52K2023£66.04K2025
-2.2%vs 2023

-1.1% a year compound (CAGR)

Total Assets

£650.09K2023£530.98K2025
-18.3%vs 2023

-9.6% a year compound (CAGR)

Total Liabilities

£582.56K2023£459.29K2025
-21.2%vs 2023

-11.2% a year compound (CAGR)

Employees

92023232025
+156%vs 2023+14

Biggest increase

Employees+156%

9 in 2023 to 23 in 2025

Biggest decrease

Total Liabilities-21.2%

£582.56K in 2023 to £459.29K in 2025

CHERRY PHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in employee numbers, pointing to an expanding team, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.

Ratios from the filed figures

Calculated from CHERRY PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
12.44%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Liabilities to total assets
86.50%2025
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Cash to liabilities
0.80%2025
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Cash to total assets
0.69%2025
Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for CHERRY PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator20212022202320242025
Net Assets£86.19K65.74K67.52K63.37K66.04K
Total Assets£787.91K680.27K650.09K605.22K530.98K
Cash in Bank£94.38K93.10K–38.19K3.65K
Total Liabilities£683.43K610.49K582.56K540.61K459.29K
Employees313292023

CHERRY PHARMA LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Yes. Okredo holds filed figures for CHERRY PHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.

CHERRY PHARMA LIMITED reported net assets of £66.04K for 2025. That compares with £63.37K in 2024, a change of 4.22%.

CHERRY PHARMA LIMITED reported total assets of £530.98K for 2025. That compares with £605.22K in 2024, a change of -12.27%.

CHERRY PHARMA LIMITED reported cash in bank of £3.65K for 2025. That compares with £38.19K in 2024, a change of -90.43%.

CHERRY PHARMA LIMITED reported 23 employees in 2025, compared with 20 in 2024.

Between 2023 and 2025, CHERRY PHARMA LIMITED's net assets fell by 2.2%, total assets fell by 18.3%, total liabilities fell by 21.2% and employee numbers rose by 156%. Net assets contracted at 1.1% a year across the two years to 2025, from £67.52K to £66.04K. Reported headcount went from 9 in 2023 to 23 in 2025 (+14).

Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.